#19 The Power of Partnerships for Drug Discovery. Anmol Nagpal.
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
概要
Anmol Nagpal is the founder and CEO of Nospharma, a pre-clinical therapeutics company developing innovative treatments for rare genetic neurodevelopmental disorders.
Prior to this, Anmol was a founder in residence at District 3 where he coached several early-stage founders and worked with them on their venture’s strategy plans.
In this episode, Anmol shares how he spun out research from McGill university into a biotech company tackling rare genetic disorders including Fragile X syndrome. It’s a candid conversation covering licensing, fundraising, partnerships to accelerate growth and early stage hurdles. Tune in to hear what it takes to bring a therapy from research to patients.
Recorded live at the 'Healthtech Social: Catalyst’ event on April 1 in Montreal.